Tick Bites
Methodology & AI Transparency ⓘ
Tick Bites Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are ticks? Ticks are small parasites.
- 2 Real-world patient consensus: Federal ICD-10-CM code W57.XXXA categorizes Tick Bites under Dermatology: Acne, Eczema, Psoriasis & Rosacea.
- 3 Typical cash cost range: Workup highlights for Tick Bites (W57.XXXA): topical retinoids/calcineurin/steroid sparing in Tick Bites (W57.XXXA: regimens).
- 4 Top reported side effects / signs: Key Skin & Dermatology biomarkers for Tick Bites (W57.XXXA): 25-Hydroxy Vitamin D in Tick Bites (W57.XXXA: & hs-CRP) & Affected Body Surface in Tick Bites (W57.XXXA: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (W57.XXXA)).
Ask our AI Specialists anything about Tick Bites
What Is Tick Bites?
What are ticks? Ticks are small parasites. They may look like insects, but they have eight legs and are related to spiders. Ticks feed on the blood of people and warm-blooded animals. There are many types of ticks in the United States, and they live in different parts of the country. Ticks can be different colors and sizes. They can be light-colored, reddish brown, or dark brown. Some ticks are so small that they can be difficult to see. Ticks may get on you if you walk though areas where they live, such as tall grass, leaf litter or shrubs.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Tick Bites (W57.XXXA, Skin & Dermatology) reflects keratinocyte hyperproliferation [Tick Bites W57.XXXA]. Cross-referenced with NIH MeSH (Tick Bites, Tick-Borne Diseases), longitudinal control is benchmarked via 25-Hydroxy Vitamin D in Tick Bites (W57.XXXA: & hs-CRP).
Common Symptoms & Clinical Signs
- • Alpha-gal syndrome (tick bite red meat allergy)
- • Rocky Mountain spotted fever
- • Presentation of Tick Bites (W57.XXXA): persistent erythematous plaques, in Tick Bites (W57.XXXA: scaly patches, pruritic)
- • Secondary Tick Bites clinical sign: compromised epidermal barrier in Tick Bites (W57.XXXA: with dryness, fissuring,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Tick Bites Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | W57.XXXA | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Tick Bites (W57.XXXA: & hs-CRP) | 25(OH)D 40–65 ng/mL (W57.XXXA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Affected Body Surface in Tick Bites (W57.XXXA: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (W57.XXXA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Lipids & in Tick Bites (W57.XXXA: ALT (if systemic) | Within baseline reference limits (W57.XXXA) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Tick Bites
Treatment selection for Tick Bites depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tick Bites)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Skin-applied tazarotene in the treatment of mild to moderate: What a 468-Participant Study Found In general, 'using the cream formulation rather than the gel formulation optimized tolerability. Cutis • 2004-10-15 • Meta-Analysis | N = 468 | 97/100 | PMID 15543714 ↗ |
| New Insights on Benefits and safety of microencapsulated benzoyl peroxide and microencapsulated: What a 571-Participant Study Found E-BPO/T provided statistically significant and clinically relevant improvements in IGA and inflammatory and noninflammatory lesion counts and was well tolerated in subjects with moderate to severe acne. Journal of the American Academy of Dermatology • 2023-10-15 • Phase III Randomized Trial | N = 571 | 93/100 | PMID 37356627 ↗ |
| Can This Approach Help? Inside the Latest Research on Dipstick proteinuria and outcomes in patients with heart failure and reduced In GALACTIC-HF, higher DP levels were independently associated with increased risk of adverse clinical outcomes in patients with reduced ejection fraction. European journal of heart failure • 2026-05-11 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41771088 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of Combined skin-applied Lidocaine and Tetracaine Cream for This study demonstrated the equivalent efficacy of CU-30101 to its reference product, Pliaglis, among Chinese adults undergoing facial fractional laser resurfacing. Journal of cosmetic dermatology • 2025-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40735955 ↗ |
| Can This Approach Help? Inside the Latest Research on Psoriasis and eczema "Resistant" to skin-applied Treatment Responds Rapidly to This may be due to better staying on track with medication in the study environment or patients' preference for the spray vehicle. Journal of cutaneous medicine and surgery • 2019-01-15 • Randomized Controlled Trial | N = 12 | 82/100 | PMID 30556414 ↗ |
Tick Bites Patient Community & “People Like Me” Threads
Filter Tick Bites community threads and patient logs by age, biological sex, dosage, and treatment duration.